COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

July 09, 2024 00:26:28
Episode Cover

Should We Use NIPPV for Preoxygenation for All Intubations?

Over 1 million critically ill patients are intubated each year in the US.  Hypoxemia occurs in up to 20% of patients and can lead...

Listen

Episode

January 29, 2019 00:30:02
Episode Cover

Episode 2

[mepr-active rule="1" ifallowed="hide"]Anything in-between gets protected[/mepr-active] hey

Listen

Episode 0

October 24, 2023 00:33:10
Episode Cover

SCCM Guidelines for RSI in the Critically Ill

RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of...

Listen